Jaskuła, K.; Nawrocka, A.; Poznański, P.; Stachowicz, A.; Łazarczyk, M.; Sacharczuk, M.; Gaciong, Z.; Skiba, D.S.
Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis. Biomedicines 2025, 13, 1802.
https://doi.org/10.3390/biomedicines13081802
AMA Style
Jaskuła K, Nawrocka A, Poznański P, Stachowicz A, Łazarczyk M, Sacharczuk M, Gaciong Z, Skiba DS.
Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis. Biomedicines. 2025; 13(8):1802.
https://doi.org/10.3390/biomedicines13081802
Chicago/Turabian Style
Jaskuła, Kinga, Agata Nawrocka, Piotr Poznański, Aneta Stachowicz, Marzena Łazarczyk, Mariusz Sacharczuk, Zbigniew Gaciong, and Dominik S. Skiba.
2025. "Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis" Biomedicines 13, no. 8: 1802.
https://doi.org/10.3390/biomedicines13081802
APA Style
Jaskuła, K., Nawrocka, A., Poznański, P., Stachowicz, A., Łazarczyk, M., Sacharczuk, M., Gaciong, Z., & Skiba, D. S.
(2025). Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis. Biomedicines, 13(8), 1802.
https://doi.org/10.3390/biomedicines13081802